A Prospective , Multi-center Registry for Patients with Short Bowel Syndrome01/01/2015 - 01/31/2030 (PI)
NPS Pharmaceuticals
NMSBS01-002: A Phase 2, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study of the Efficacy, Safety, and Tolerability of NM-002 in Adult Patients with Short Bowel Syndrome11/15/2021 - 11/14/2024 (PI)
9 Meters Biopharma, Inc.
MACS-2020-11 19011 Teduglutide for Treatment of Short Bowel Syndrome in Real World Settings: Center-based Chart Review in the US09/08/2021 - 02/15/2023 (PI)
Analysis Group, Inc.